Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2009 16:15 ET | Source: Penwest Pharmaceuticals Co.

Penwest Second Quarter 2009 Financial Results Conference Call

DANBURY, Conn., July 29, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, August 7, at 11:00 a.m. EDT to review its financial results for...
July 16, 2009 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Announces Results of Phase Ib Trial of A0001

DANBURY, Conn., July 16, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the results of its Phase Ib clinical trial of A0001, a compound the Company is developing...
June 24, 2009 16:30 ET | Source: Penwest Pharmaceuticals Co.

Penwest Announces That the Results of Its Annual Meeting Have Been Certified

DANBURY, Conn., June 24, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that IVS Associates, Inc., the independent inspector of election for the Company's Annual...
June 17, 2009 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical

DANBURY, Conn., June 17, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed its third research and development agreement with Otsuka Pharmaceutical...
June 10, 2009 13:41 ET | Source: Penwest Pharmaceuticals Co.

Penwest Announces Preliminary Vote Count At Annual Meeting

DANBURY, Conn., June 10, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the preliminary results of its Annual Meeting of Shareholders, which was held today. Based...
June 09, 2009 10:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Urges Shareholders to Vote the White Proxy Card Today and Reject Dissident Proposals and Nominees At Wednesday's Annual Meeting

Just Announced Licensing Agreement for Opana ER(r) Outside U.S. is Tangible Evidence That Penwest is Successfully Executing Its Strategy to Build Shareholder Value ...
June 09, 2009 07:30 ET | Source: Penwest Pharmaceuticals Co.

Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand

DANBURY, Conn., CHADDS FORD, Pa., and ALISO VIEJO, Calif., June 9, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO), Endo Pharmaceuticals (Nasdaq:ENDP) and Valeant Pharmaceuticals...
June 01, 2009 16:47 ET | Source: Penwest Pharmaceuticals Co.

Leading Proxy Advisory Firms RiskMetrics Group and Glass Lewis Recommend Penwest Shareholders Vote Against All Three Dissident Proxy Proposals

Firms Unconvinced by Dissidents' Wind-Down Proposal Penwest Urges Shareholders to Vote FOR Its Director Nominees and AGAINST Dissidents' Proposals On the WHITE Proxy Card,...
May 22, 2009 16:12 ET | Source: Penwest Pharmaceuticals Co.

Washington State Court Denies Dissidents' Request for Preliminary Injunction in Penwest Proxy Vote

Company Plans to Proceed with Voting for Two Director Seats at June 10 Annual Meeting Strongly Urges Shareholders to Vote Against Tang Capital and ...
May 19, 2009 09:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Urges Shareholders to Reject Tang Capital and Perceptive's Wind Down Proposal

DANBURY, Conn., May 19, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today sent a letter to its shareholders in connection with the Company's annual meeting to be held on June...